The essential role of endogenous IFN α/β in the anti‐metastatic action of sensitized T lymphocytes in mice injected with friend erythroleukemia cells
- 27 November 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 63 (5) , 726-731
- https://doi.org/10.1002/ijc.2910630520
Abstract
Adoptive transfer of splenic T lymphocytes from DBA/2 mice immunized against Friend erythroleukemia cells (FLC) inhibited the development of visceral metastases and increased the survival time of DBA/2 mice challenged i.v. with parental FLC 24 hr to 2 months later. Immune spleen cells were ineffective in mice pre-treated with potent neutralizing antibody to mouse IFN α/β (but not to IFN γ), demonstrating the essential participation of endogenous IFN α/β in the inhibitory action of immune T lymphocytes against FLC metastases. These findings suggest that the reported inability of immune T lymphocytes to exert an anti-FLC effect in immunodeficient DBA/2 mutant beige (bg/bg) mice (unless these mice had also been treated with IFN α/β), may have been due to lower levels of endogenous IFN α/β in DBA/2 bg/bg mice than in normal DBA/2 +/bg mice. Experimental results in support of this hypothesis are presented. © 1995 Wiley-Liss, Inc.Keywords
This publication has 25 references indexed in Scilit:
- Interaction of IFN α/β with host cells essential to the early inhibition of friend erythroleukemia visceral metastases in miceInternational Journal of Cancer, 1994
- Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN α/β therapy of friend erythroleukemia visceral metastasesInternational Journal of Cancer, 1993
- Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice.The Journal of Experimental Medicine, 1991
- Anti‐tumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastasesInternational Journal of Cancer, 1990
- Modification of tumor cells by a low dose of Newcastle disease virusCellular Immunology, 1990
- Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.The Journal of Experimental Medicine, 1988
- Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.The Journal of Experimental Medicine, 1986
- Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors.The Journal of Experimental Medicine, 1983
- The beige mutation in the mouse selectively impairs natural killer cell functionNature, 1979
- Purification of mouse interferon by sequential affinity chromatography on poly(U)– and antibody–agarose columnsNature, 1978